SBIO (ALPS Medical Breakthroughs ETF) Stock Analysis - Politician Trades
ALPS Medical Breakthroughs ETF (SBIO) is a publicly traded the market company. As of May 21, 2026, SBIO trades at $58.43 with a market cap of $0 and a P/E ratio of 0.00. SBIO moved +0.00% today. Year to date, SBIO is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $0.00 to $0.00. Rallies surfaces SBIO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Which politicians traded SBIO stock?
Recent politician trading activity in SBIO includes disclosures from Thomas R. Carper, Thomas R. Carper, Thomas R. Carper, Thomas R. Carper, and Thomas R. Carper. Rallies tracks purchase and sale disclosures, transaction dates, owners, reported amounts, and post-trade performance context.
SBIO Key Metrics
Key financial metrics for SBIO
Metric
Value
Price
$58.43
Market Cap
$0
P/E Ratio
0.00
EPS
$0.00
Dividend Yield
0.00%
52-Week High
$0.00
52-Week Low
$0.00
Volume
114.58K
Avg Volume
0
Revenue (TTM)
$0
Net Income
$0
Gross Margin
0.00%
Congressional Trades in SBIO
Thomas R. Carper sale (full) SBIO on Apr 17, 2023 (amount: $15.00K) for Spouse.
Thomas R. Carper sale (full) SBIO on Feb 15, 2023 (amount: $15.00K) for Spouse.
Thomas R. Carper sale (full) SBIO on Oct 4, 2022 (amount: $15.00K) for Spouse.
Thomas R. Carper sale (partial) SBIO on Mar 7, 2022 (amount: $15.00K) for Spouse.
Thomas R. Carper sale (partial) SBIO on Dec 31, 2021 (amount: $15.00K) for Spouse.
SBIO Analyst Consensus
SBIO analyst coverage data. Average price target: $0.00.
Common questions about SBIO
Which politicians traded SBIO stock?
Recent politician trading activity in SBIO includes disclosures from Thomas R. Carper, Thomas R. Carper, Thomas R. Carper, Thomas R. Carper, and Thomas R. Carper. Rallies tracks purchase and sale disclosures, transaction dates, owners, reported amounts, and post-trade performance context.
Does Rallies track congressional trades in SBIO?
Yes. Rallies tracks politician and congressional stock disclosures for SBIO, including reported purchases, sales, dates, owners, and trade amounts when available.
Is SBIO research on Rallies investment advice?
No. Rallies provides research, data, and educational context for SBIO. It does not provide personalized investment advice.